The Canada cannabis standard is truly making waves globally with dispensaries ready to participate in the marijuana rush happening in Germany, the most populated European country, and now with Australia coming to learn just how Canada pulls off its medical marijuana program. The United States, in the meantime, seems to be missing out with the current big government administration interfering with the cannabis industry. Were you under the impression that conservatives were pro-business?
Marijuana legalization may not be a top priority for the United States right now, but change is occurring all over the world.
The last two years have been very significant for the global marijuana industry and countries like Germany, Chile, Colombia, Mexico, and Uruguay have legalized medical marijuana at the federal level.
While the United States sits back, the legal cannabis industry continues to grow and is already a multi-billion-dollar global phenomenon. The upcoming meeting between an Australian delegation and Canadian federal officials in Ottawa is a perfect example of how the marijuana industry is advancing without the United States.
The purpose of this meeting is simple. Australia wants to better understand the elements that helped Canada create a very successful medical marijuana program that treats almost 200,000 registered patients.
Global Cannabis Leader to Host Australian Delegation
Aurora Cannabis Inc. (ACB.V) (ACBFF) has been making waves in the global marijuana industry and the company has executed flawlessly to become an industry leader.
The Australian delegation will spend a full day with Aurora executives and will visit its two facilities. The purpose of the visit is for a knowledge transfer regarding the regulations governing the medical cannabis sector, as well as more detailed insight into best practices relating to cultivation, production and distribution.
The timing of the visit is significant and takes place six-weeks after Cann Group Limited (ASX: CAN) became the first Australian company to be licensed by the Office of Drug Control for commercial medical cannabis cultivation and production.
Cann Group’s expansion project is fully funded and the company is focused on completing the buildout of its facilities, securing licenses for expansion purposes, and executing on its business plan. If everything goes to plan, the company expects to harvest its initial crop in early August.
The post Canada Cannabis Standard for Medical Patients Being Duplicated Globally appeared first on Marijuana News.